Future Oncology Journal Issues Research Articles in Vol. 18, No. 34
January 16, 2023
January 16, 2023
LONDON, England, Jan. 16 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 18, No. 34 edition:
Clinical Trial Protocol:
* GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer
* Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial
Short Commu . . .
Clinical Trial Protocol:
* GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer
* Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial
Short Commu . . .